Malta Deal?, page-2

First 2 Last

Share
Profile

Follow
28four77

3,061 Posts.

366

08/05/18

16:27

Post #: 32961130
Share

Originally posted by nrcmedia ↑

I am still a little confused by the significance of the Malta thing. The government purportedly approved a 4000 sq. metre plot for growing....? Is this a cannabis 'farming' company or a 'pharma' company?
The reason I ask, is because most cannabis companies that I am aware of in Israel, US, Canada, Australia, etc. are either in the production and sales part of the cannabis industry for dispensaries...or they are in the pharmaceutical part. Maybe I am mistaken...but my interpretation is they are trying to develop cannabis related drugs, rather than producing in mass for dispensaries. All of the pharma cannabis companies I am aware of do their growing indoors so they can control all of the factors in the growing cycle. Is this Malta deal a step in a different direction for the company? I thought when I originally bought the stock that the company was producing their cannabis in an indoor controlled facility in eastern europe to produce 'cannEpil' (or whatever they call it). The more I read and the more questions I ask about the company the more confused I get about their mission. Maybe my uneducated greed is clouding my vision.
Making a comparison in industries for argument's sake. When Lithium starting taking off a few years ago most of the producers were either 'hard rock' or 'lithium carbonate' miners....but they were all trying to get a share of the world lithium market which was expanding exponentially. Cannabis is very similar from the standpoint of having a huge market open for it with legalization, the same as EV's have accelerated the demand for lithium. So, if you're a marijuana producer you need to determine how you're going to grow and develop your company in the industry. That requires a laser focus in order to capitalize in an industry that is going to have a lot of companies strewn along the highway as roadkill.
This Malta deal doesn't seem to be a necessary acquisition in light of the fact that they will have to build a facility to produce pharma grade cannabis...which they already have in eastern europe. If the idea is to farm outdoors...that is a bad idea for a pharma company...if it's to get into a jurisdiction that allows them to produce and export....they still need to get permission from the importing countries. So...yes I would like to be more tactically informed by management as to how and why Malta is a necessary or helpful acquisition other than another location. Because if that's the point, there are better locations for both growing and banking.

Expand

because you love to research

who are the other four company's involved with the malta deal??

MXC Price at posting: 7.2¢ Sentiment: Buy Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

TLX

Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug

AUG

Augustus sees imperial share rise on high-grade Cu and gold results at Ti-Tree

I88

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

RNU

Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some

TX3

Canadian fieldwork yields multiple pegmatites for Trinex

There are more pages in this discussion • 10 more messages in this thread...

First 2 Last

Add RGT (ASX) to my watchlist

(20min delay)
Last 30.5¢		Change 0.015(5.17%)		Mkt cap ! $13.31M

Open	High	Low	Value	Volume
29.0¢	30.5¢	29.0¢	$577	1.938K

Buyers (Bids)

No.	Vol.	Price($)
2	3844	29.0¢

Sellers (Offers)

Price($)	Vol.	No.
30.5¢	45098	2

View Market Depth

No.	Vol.	Price($)
2	3844	0.290
1	7264	0.280
2	18800	0.275
2	20000	0.270
1	4000	0.250

Price($)	Vol.	No.
0.305	45098	2
0.315	2825	2
0.340	2115	2
0.370	1056	1
0.390	3420	1

Last trade - 11.40am 11/07/2024 (20 minute delay)

RGT (ASX) Chart

Malta Deal?, page-2

Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug

Augustus sees imperial share rise on high-grade Cu and gold results at Ti-Tree

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some

Canadian fieldwork yields multiple pegmatites for Trinex

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Malta Deal?, page-2

Top Stories

Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug

Augustus sees imperial share rise on high-grade Cu and gold results at Ti-Tree

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some

Canadian fieldwork yields multiple pegmatites for Trinex

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News